This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1985 Jan;106(1):76-8.

doi: 10.1016/s0022-3476(85)80471-6.

Coronary arterial thrombi in Kawasaki disease

M Terai, M Ogata, K Sugimoto, Y Nagai, T Toba, K Tamai, H Aotsuka, K Niwa, H Nakajima

PMID: 3965685
DOI: 10.1016/s0022-3476(85)80471-6

Case Reports

Coronary arterial thrombi in Kawasaki disease

M Terai et al. J Pediatr. 1985 Jan.

. 1985 Jan;106(1):76-8.

doi: 10.1016/s0022-3476(85)80471-6.

Authors

M Terai, M Ogata, K Sugimoto, Y Nagai, T Toba, K Tamai, H Aotsuka, K Niwa, H Nakajima

PMID: 3965685
DOI: 10.1016/s0022-3476(85)80471-6

No abstract available

PubMed Disclaimer

Similar articles

[Intracoronary thrombolytic therapy in Kawasaki disease and the usefulness of two-dimensional echocardiography in detecting intracoronary thrombi].
Ichinose E, Kato H, Inoue O, Hirata K, Eto Y, Yoshioka F. Ichinose E, et al. J Cardiogr. 1985 Mar;15(1):79-87. J Cardiogr. 1985. PMID: 4067350 Japanese.
Low-dose i.v. urokinase for coronary thrombosis in Kawasaki disease.
Serizawa H, Lin L, Sato T, Takahashi-Igari M, Kato Y. Serizawa H, et al. Pediatr Int. 2019 Mar;61(3):302-303. doi: 10.1111/ped.13783. Epub 2019 Mar 10. Pediatr Int. 2019. PMID: 30854729 No abstract available.
Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction.
Kato H, Inoue O, Ichinose E, Akagi T, Sato N. Kato H, et al. Acta Paediatr Jpn. 1991 Feb;33(1):27-35. doi: 10.1111/j.1442-200x.1991.tb01516.x. Acta Paediatr Jpn. 1991. PMID: 1853711
Kawasaki disease.
Kato H, Akagi T, Sugimura T, Sato N, Kazue T, Hashino K, Nishiyori A, Sakaguchi M. Kato H, et al. Coron Artery Dis. 1995 Mar;6(3):194-206. Coron Artery Dis. 1995. PMID: 7788031 Review. No abstract available.
Kawasaki disease in Nebraska: a review of the literature.
Cheatham JP, Kugler JD, Pinsky WW, Hofschire PJ. Cheatham JP, et al. Nebr Med J. 1983 Sep;68(9):282-93. Nebr Med J. 1983. PMID: 6355872 Review. No abstract available.

See all similar articles

Cited by

Vasculitis from the pediatric perspective.
Brogan PA, Dillon MJ. Brogan PA, et al. Curr Rheumatol Rep. 2000 Oct;2(5):411-6. doi: 10.1007/s11926-000-0041-7. Curr Rheumatol Rep. 2000. PMID: 11123091 Review.
Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease.
Tsubata S, Ichida F, Hamamichi Y, Miyazaki A, Hashimoto I, Okada T. Tsubata S, et al. Pediatr Cardiol. 1995 Jul-Aug;16(4):186-9. doi: 10.1007/BF00794192. Pediatr Cardiol. 1995. PMID: 7567665
Low-dose antithrombotic treatment in coronary thrombosis of Kawasaki disease.
Peng H, Wu Z, Liu Y, Li L, Kong S, Wu J, Liu Y. Peng H, et al. Pediatr Cardiol. 2015 Mar;36(3):503-8. doi: 10.1007/s00246-014-1040-1. Epub 2014 Oct 9. Pediatr Cardiol. 2015. PMID: 25298222
Combination thrombolytic and anti-platelet therapies in an infant with incomplete kawasaki disease and coronary aneurysms.
Johnson PN, Kuhn RJ. Johnson PN, et al. J Pediatr Pharmacol Ther. 2008 Oct;13(4):242-50. doi: 10.5863/1551-6776-13.4.242. J Pediatr Pharmacol Ther. 2008. PMID: 23055883 Free PMC article.
New perspectives in the drug treatment of Kawasaki disease.
Shingadia D, Shulman ST. Shingadia D, et al. Paediatr Drugs. 1999 Oct-Dec;1(4):291-7. doi: 10.2165/00128072-199901040-00005. Paediatr Drugs. 1999. PMID: 10935427 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information